Discontinued — last reported Q3 '22

Investing

Acquisitions

Abbott Acquisitions remained flat by 0.0% to $26.25M in Q4 2025 compared to the prior quarter. Over 4 years (FY 2021 to FY 2025), Acquisitions shows a downward trend with a -13.4% CAGR.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ4 2013
Last reportedQ3 2022

How to read this metric

High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.

Detailed definition

This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...

Peer comparison

Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.

Metric ID: cf_acquisitions

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$0.00$172.00M$0.00$0.00$0.00$0.00$0.00$219.25M$219.25M$219.25M$219.25M$0.00$0.00$0.00$0.00$26.25M$26.25M$26.25M$26.25M
QoQ Change-100.0%+0.0%+0.0%+0.0%-100.0%+0.0%+0.0%+0.0%
YoY Change-100.0%-100.0%-100.0%-100.0%-100.0%
Range$0.00$219.25M
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Current Streak3+ quarters growth

Frequently Asked Questions

What is Abbott's acquisitions?
Abbott (ABT) reported acquisitions of $26.25M in Q4 2025.
What is the long-term trend for Abbott's acquisitions?
Over 4 years (2021 to 2025), Abbott's acquisitions has grown at a -13.4% compound annual growth rate (CAGR), from $187.00M to $105.00M.
What does acquisitions mean?
Cash spent to acquire other companies or businesses, net of cash received in the deal.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.